This fact sheet summarizes the work being done by PATH to develop two new tests to detect infection with cancer-causing human papillomavirus. Designed by the private sector—in partnership with PATH—for use in low-resource settings, these molecular and biochemical screening tools are an innovative answer to the challenge of preventing cervical cancer in the developing world.

Author(s): Lim J, Sellors J

Corporate author(s): PATH, QIAGEN, AVC

Publication date: December 2007

Region: Global

See also:

Reproductive health > Cervical cancer prevention

Health technologies > Diagnostic technologies

For more information…

Contact: PATH Publications
Email: publications@path.org
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA